{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:04:43Z","timestamp":1777539883431,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81371477"],"award-info":[{"award-number":["81371477"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009670","name":"NARSAD","doi-asserted-by":"publisher","award":["20314"],"award-info":[{"award-number":["20314"]}],"id":[{"id":"10.13039\/100009670","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.schres.2017.10.027","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T11:00:49Z","timestamp":1508410849000},"page":"488-494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Prevalence, risk factors and clinical characteristics of osteoporosis in Chinese inpatients with schizophrenia"],"prefix":"10.1016","volume":"195","author":[{"given":"Jingyi","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Mei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Fei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangya","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuping","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan M.","family":"Cassidy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jair C.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingbing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2017.10.027_bb0005","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/09513590802549817","article-title":"Risk factors for postmenopausal osteoporosis: anthropometric measurements, age, age at menopause and the time elapsed after menopause onset","volume":"25","author":"Akdeniz","year":"2009","journal-title":"Gynecol. Endocrinol."},{"issue":"6","key":"10.1016\/j.schres.2017.10.027_bb0010","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00198-003-1562-5","article-title":"Risk factors for low bone mineral density and the 6-year rate of bone loss among premenopausal and perimenopausal women","volume":"15","author":"Bainbridge","year":"2004","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.schres.2017.10.027_bb0015","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/00207450290025833","article-title":"Classical and atypical neuroleptics, and bone mineral density, in patients with schizophrenia","volume":"112","author":"Bilici","year":"2002","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.schres.2017.10.027_bb0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00198-003-1538-5","article-title":"Amylin fasting plasma levels are decreased in patients with osteoporosis","volume":"15","author":"Bronsky","year":"2004","journal-title":"Osteoporos. Int."},{"issue":"3","key":"10.1016\/j.schres.2017.10.027_bb0025","first-page":"255","article-title":"The effect of antipsychotics on bone mineral density and sex hormones in male patients with schizophrenia","volume":"28","author":"Bulut","year":"2016","journal-title":"Psychiatr. Danub."},{"issue":"7","key":"10.1016\/j.schres.2017.10.027_bb0030","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1177\/0269881107078281","article-title":"Prevalence of hyperprolactinemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics","volume":"21","author":"Bushe","year":"2007","journal-title":"J. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.schres.2017.10.027_bb0035","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00198-008-0593-3","article-title":"Regional variations of vertebral trabecular bone microstructure with age and gender","volume":"19","author":"Chen","year":"2008","journal-title":"Osteoporos. Int."},{"issue":"3","key":"10.1016\/j.schres.2017.10.027_bb0040","doi-asserted-by":"crossref","first-page":"238","DOI":"10.9758\/cpn.2016.14.3.238","article-title":"Effects of antipsychotics on bone mineral density in patients with schizophrenia: gender differences","volume":"14","author":"Chen","year":"2016","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"3","key":"10.1016\/j.schres.2017.10.027_bb0045","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/BOT.0b013e3181b8b036","article-title":"A comparison of quantitative ultrasound of the calcaneus with dual-energy X-ray absorptiometry in hospitalized orthopaedic trauma patients","volume":"24","author":"Collinge","year":"2010","journal-title":"J. Orthop. Trauma"},{"key":"10.1016\/j.schres.2017.10.027_bb0050","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/schbul\/sbn018","article-title":"Antipsychotic combinations vs. monotherapy in schizophrenia: a meta-analysis of randomized controlled trials","volume":"35","author":"Correll","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2017.10.027_bb0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hup.1265","article-title":"Is antipsychotic treatment linked to low bone mineral density and osteoporosis? A review of the evidence and the clinical implications","volume":"27","author":"Crews","year":"2012","journal-title":"Hum. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.schres.2017.10.027_bb0060","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1517\/14740338.2016.1167873","article-title":"Relationship between antipsychotic medication, serum prolactin levels and osteoporosis\/osteoporotic fractures in patients with schizophrenia: a critical literature review","volume":"15","author":"De Hert","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"issue":"3","key":"10.1016\/j.schres.2017.10.027_bb0065","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000329391","article-title":"Bone remodeling, bone mass and weight gain in patients with stabilized schizophrenia in real-life conditions treated with long-acting injectable risperidone","volume":"94","author":"Doknic","year":"2011","journal-title":"Neuroendocrinology"},{"issue":"2","key":"10.1016\/j.schres.2017.10.027_bb0070","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1210\/jc.2014-3421","article-title":"Clinical review: drugs commonly associated with weight change: a systematic review and meta-analysis","volume":"100","author":"Domecq","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.schres.2017.10.027_bb0075","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11914-016-0325-0","article-title":"Lower bone mineral density at the hip and lumbar spine in people with psychosis versus controls: a comprehensive review and skeletal site-specific meta-analysis","volume":"14","author":"Gomez","year":"2016","journal-title":"Curr. Osteoporos. Rep."},{"issue":"1","key":"10.1016\/j.schres.2017.10.027_bb0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1017\/S1461145708009085","article-title":"Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5knockout mouse: association with N-methyl-d-aspartic acid receptor up-regulation","volume":"12","author":"Gray","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2017.10.027_bb0085","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2165\/00023210-200721080-00003","article-title":"Osteoporosis, schizophrenia and antipsychotics: the need for a comprehensive multifactorial evaluation","volume":"21","author":"Halbreich","year":"2007","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1016\/j.schres.2017.10.027_bb0090","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00006842-199509000-00011","article-title":"Decreased bone mineral density in medicated psychiatric patients","volume":"57","author":"Halbreich","year":"1995","journal-title":"Psychosom. Med."},{"issue":"12","key":"10.1016\/j.schres.2017.10.027_bb0095","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1007\/s00198-005-1928-y","article-title":"Down-regulation of N-methyl d-aspartate receptor in rat-modeled disuse osteopenia","volume":"16","author":"Ho","year":"2005","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.schres.2017.10.027_bb0100","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jamda.2009.10.001","article-title":"Antipsychotic use and the risk of hip fracture among older adults afflicted with dementia","volume":"11","author":"Jalbert","year":"2010","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.schres.2017.10.027_bb0105","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.4088\/JCP.v67n0909","article-title":"Prevalence of bone mineral density loss in Korean patients with schizophrenia, a cross-sectional study","volume":"67","author":"Jung","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2017.10.027_bb0110","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/JCP.0b013e318221b123","article-title":"Bone mineral density and osteoporosis risk in older patients with schizophrenia","volume":"31","author":"Jung","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2017.10.027_bb0115","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(02)08761-5","article-title":"Osteoporosis III: diagnosis of osteoporosis and assessment of fracture risk","volume":"359","author":"Kanis","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2017.10.027_bb0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00198-012-2074-y","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"24","author":"Kanis","year":"2013","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.schres.2017.10.027_bb0125","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s00223-008-9182-x","article-title":"Assessment of clinical risk factors to validate the probability of osteoporosis and subsequent fractures in Korean women","volume":"83","author":"Kim","year":"2008","journal-title":"Calcif. Tissue Int."},{"issue":"Suppl. 2","key":"10.1016\/j.schres.2017.10.027_bb0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0306-4530(02)00127-0","article-title":"Prevalence of hyperprolactinemia in schizophrenia patients treated with conventional antipsychotic medications or risperidone","volume":"28","author":"Kinon","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2017.10.027_bb0135","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3371\/CSRP.KISE.020113","article-title":"Bone loss associated with hyperprolactinemia in patients with schizophrenia","volume":"7","author":"Kinon","year":"2013","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"issue":"5","key":"10.1016\/j.schres.2017.10.027_bb0140","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/YCO.0b013e328355e1ac","article-title":"Osteoporosis and fracture risk in people with schizophrenia","volume":"25","author":"Kishimoto","year":"2012","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.schres.2017.10.027_bb0145","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12888-016-0780-2","article-title":"Clinical correlates of vitamin D deficiency in established psychosis","volume":"16","author":"Lally","year":"2016","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2017.10.027_bb0150","article-title":"Hyperprolactinaemia in first episode psychosis - a longitudinal assessment","volume":"17","author":"Lally","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2017.10.027_bb0155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2147\/CIA.S100274","article-title":"Factors associated with decreased bone mineral density in postmenopausal women with schizophrenia","volume":"11","author":"Liang","year":"2016","journal-title":"Clin. Interv. Aging"},{"issue":"7","key":"10.1016\/j.schres.2017.10.027_bb0160","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1017\/S1461145711001507","article-title":"Clozapine protects bone mineral density in female patients with schizophrenia","volume":"15","author":"Lin","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.schres.2017.10.027_bb0165","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/YIC.0000000000000062","article-title":"Sex-specific factors for bone density in patients with schizophrenia","volume":"30","author":"Lin","year":"2015","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.10.027_bb0170","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.schres.2007.01.013","article-title":"Bone mineral density changes over a year in young females with schizophrenia: relationship to medication and endocrine variables","volume":"93","author":"Meaney","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2017.10.027_bb0175","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1192\/bjp.184.6.503","article-title":"Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia","volume":"184","author":"Meaney","year":"2004","journal-title":"Br. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2017.10.027_bb0180","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3371\/CSRP.3.3.4","article-title":"The importance of screening for osteoporosis in mental health settings","volume":"3","author":"Miller","year":"2009","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"10.1016\/j.schres.2017.10.027_bb0190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0306-4530(02)00129-4","article-title":"Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents","volume":"28","author":"Naidoo","year":"2003","journal-title":"Psychoneuroendocrinology"},{"issue":"2 Suppl","key":"10.1016\/j.schres.2017.10.027_bb0195","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/0269881107088439","article-title":"Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia","volume":"22","author":"O'Keane","year":"2008","journal-title":"J. Psychopharmacol."},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.10.027_bb0200","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.schres.2014.05.009","article-title":"Second-generation antipsychotics and bone turnover in schizophrenia","volume":"157","author":"Okita","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2017.10.027_bb0205","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1749-6632.2009.05317.x","article-title":"Genetics of osteoporosis","volume":"1192","author":"Ralston","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"5","key":"10.1016\/j.schres.2017.10.027_bb0210","doi-asserted-by":"crossref","DOI":"10.1210\/er.2009-0044","article-title":"Genetics of osteoporosis","volume":"31","author":"Ralston","year":"2010","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.schres.2017.10.027_bb0215","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S8756-3282(02)00864-5","article-title":"Relationships among body mass, its components, and bone","volume":"31","author":"Reid","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.schres.2017.10.027_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2474-10-1","article-title":"Bone mass in schizophrenia and normal populations across different decades of life","volume":"10","author":"Renn","year":"2009","journal-title":"BMC Musculoskelet. Disord."},{"issue":"2","key":"10.1016\/j.schres.2017.10.027_bb0225","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1359\/jbmr.071020","article-title":"A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men","volume":"23","author":"Riggs","year":"2008","journal-title":"J. Bone Miner. Res."},{"issue":"339","key":"10.1016\/j.schres.2017.10.027_bb0230","first-page":"2343","article-title":"Body size accounts for most differences in bone density between Asian and Caucasian women","volume":"59","author":"Ross","year":"1996","journal-title":"Calcif. Tissue Int."},{"issue":"5\u20136","key":"10.1016\/j.schres.2017.10.027_bb0235","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.lfs.2008.05.014","article-title":"Clozapine interacts with the glycine site of the NMDA receptor: electrophysiological studies of dopamine neurons in the rat ventral tegmental area","volume":"83","author":"Schwieler","year":"2008","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.schres.2017.10.027_bb0240","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jocd.2007.08.006","article-title":"T-score and z-scores","volume":"10","author":"Shepherd","year":"2007","journal-title":"J. Clin. Densitom."},{"issue":"6","key":"10.1016\/j.schres.2017.10.027_bb0245","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/acps.12313","article-title":"A meta-analysis of prevalence estimates and moderators of low bone mass in people with schizophrenia","volume":"130","author":"Stubbs","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2017.10.027_bb0250","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.genhosppsych.2015.01.004","article-title":"Schizophrenia and the risk of fractures: a systematic review and comparative meta-analysis","volume":"37","author":"Stubbs","year":"2015","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.schres.2017.10.027_bb0255","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.schres.2016.05.017","article-title":"How much physical activity do people with schizophrenia engage in? A systematic review, comparative meta-analysis and meta-regression","volume":"176","author":"Stubbs","year":"2016","journal-title":"Schizophr. Res."},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.10.027_bb0260","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.schres.2016.01.034","article-title":"How sedentary are people with psychosis? A systematic review and meta-analysis","volume":"171","author":"Stubbs","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2017.10.027_bb0265","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1744-859X-11-5","article-title":"Effect of age and disease on bone mass in Japanese patients with schizophrenia","volume":"11","author":"Sugawara","year":"2012","journal-title":"Ann. General Psychiatry"},{"key":"10.1016\/j.schres.2017.10.027_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2007-993224","article-title":"Clozapine in China","volume":"41","author":"Tang","year":"2008","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1016\/j.schres.2017.10.027_bb0275","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1192\/bjp.bp.115.177139","article-title":"Solving a weighty problem: systematic review and meta-analysis of nutrition interventions in severe mental illness","volume":"210","author":"Teasdale","year":"2017","journal-title":"Br. J. Psychiatry"},{"issue":"47","key":"10.1016\/j.schres.2017.10.027_bb0280","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001967","article-title":"Bone mineral density in schizophrenia: an update of current meta-analysis and literature review under guideline of PRISMA","volume":"94","author":"Tseng","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.schres.2017.10.027_bb0285","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.schres.2012.10.031","article-title":"Bone mineral density as a marker of cumulative endogenous estrogen exposure: relationship to background genetic risk of psychotic disorder","volume":"143","author":"van der Leeuw","year":"2013","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2017.10.027_bb0290","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/wps.20309","article-title":"Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis","volume":"15","author":"Vancampfort","year":"2016","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2017.10.027_bb0295","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/hup.2387","article-title":"Effects of antipsychotics on bone mineral density and prolactin levels in patients with schizophrenia: a 12-month prospective study","volume":"29","author":"Wang","year":"2014","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.schres.2017.10.027_bb0300","series-title":"WHO Technical Report Series No. 843","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis","author":"World Health Organization Study Group","year":"1994"},{"key":"10.1016\/j.schres.2017.10.027_bb0305","series-title":"Clinical Pharmacy Pocket Companion","author":"Wright","year":"2015"},{"key":"10.1016\/j.schres.2017.10.027_bb0310","doi-asserted-by":"crossref","first-page":"167138","DOI":"10.1155\/2013\/167138","article-title":"Osteoporosis associated with antipsychotic treatment in schizophrenia","volume":"2013","author":"Wu","year":"2013","journal-title":"Int. J. Endocrinol."},{"issue":"5","key":"10.1016\/j.schres.2017.10.027_bb0315","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00198-009-1010-2","article-title":"A survey of bone mineral density of healthy Han adults in China","volume":"21","author":"Zhu","year":"2010","journal-title":"Osteoporos. Int."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417306552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417306552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T09:40:12Z","timestamp":1565343612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996417306552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":62,"alternative-id":["S0920996417306552"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2017.10.027","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence, risk factors and clinical characteristics of osteoporosis in Chinese inpatients with schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2017.10.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}